Cue Health

ASPR's IBx Portfolio

Product: Tests-SARS-COV-2

Description of Project: Cue Health was contracted to ramp-up production of its hand-held diagnostic test for COVID-19.

Unique Impact: The company’s rapid molecular test is based on a nasal swab and a cartridge-based reader and delivers results through a smartphone within about 20 minutes. Cue Health was contracted to provide 30,000 of the reusable, battery-powered instruments by March 2021, while increasing production of its testing kits to 100,000 per day.

Base Award Amount: $480,916,636.62

Category: Testing Capacity and Raw Materials